[14 C] Study on Mass Balance of TY-9591 in Healthy Chinese Adult Male Subjects
Latest Information Update: 03 Jan 2025
At a glance
- Drugs TY 9591 (Primary)
- Indications Brain metastases; Non-small cell lung cancer; Solid tumours
- Focus Pharmacodynamics
- Sponsors TYK Medicine
- 30 Dec 2024 Status changed from recruiting to completed.
- 15 Nov 2023 Status changed from not yet recruiting to recruiting.
- 25 May 2023 New trial record